Variant Pharmaceuticals, founded in Weston, Florida, is a development-stage specialty pharmaceutical company. The organization leverages proprietary technologies to create and develop formulations aimed at improving therapies for patients, particularly in Men’s Health. With a team boasting over 120 years of combined biopharmaceutical industry experience, Variant focuses on addressing large and growing markets where current treatments are either suboptimal or underdeveloped.
Notable figures affiliated with Variant Pharmaceuticals include seasoned professionals with extensive backgrounds in the biopharmaceutical sector. The company has made significant strides in developing innovative therapies that have the potential to transform patient care. Through its focused approach and expert team, Variant has established itself as a key player in the specialty pharmaceutical space, driving advancements in therapeutic solutions and impacting the broader healthcare market.
ZyVersa Therapeutics' most recent funding round was for $10M (USD) in December 2018.
As of Dec 3, 2018, ZyVersa Therapeutics has disclosed funding of $14.4M (USD).

Variant Bio
variantbio.com
Manhattan Pharmaceuticals

Vertice Pharma

BiotechInnova
biotechinnova.com

Marius Pharmaceuticals
mariuspharma.com

Vitruvias Therapeutics
vitruvias.com

Solaris Pharma
solaris-pharma.com
Fervent Pharmaceuticals
ferventpharma.com

Petros Pharmaceuticals
petrospharma.com

Roivant Sciences
roivant.com

Aytu BioPharma
aytubio.com

Visiox
visioxpharma.com

Aquavit Pharmaceuticals
aquavitpharma.com

Karyopharm Therapeutics
karyopharm.com

Vast Therapeutics

Vesalius Therapeutics
vesaliustx.com

Theracos
theracos.com

EIR Pharmaceuticals

Response Pharmaceuticals

Auxilius Pharma
auxiliuspharma.com